corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 9416

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Smith J.
The contribution of infant food marketing to the obesogenic environment in Australia.
Breastfeed Rev 2007 Mar; 15:(1):23-35
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17424655&dopt=Abstract


Abstract:

Obesity has been growing rapidly among both children and adult Australians in recent decades, raising concern at the associated chronic disease burden, and generating debate over the extent of individual versus government responsibility. This paper briefly reviews recent scientific evidence on links between poor early life nutrition and obesity in later life, which suggests that artificial baby milk rather than breastfeeding in infancy is associated with a 30-50% higher likelihood of later life obesity. It then presents data on long-term trends in breastfeeding in Australia and on consumption of infant milk products since 1939. Evidence is also presented of increased marketing and promotion of breastmilk substitutes from the mid 1950s, including through the healthcare system, associated with the emergence of increased competition in the Australian infant food industry. This collaborative marketing effort by industry and health professionals in turn contributed importantly to the sharp decline in breastfeeding from the mid 1950s. As a consequence, most Australians born since 1955 were exposed to artificial baby milk in early infancy. A substantial proportion of Australian infants are still partially fed with artificial baby milk in the first 12 months of life. The example of infant food highlights that the healthcare system and the food industry, and not just individual mothers’ choices, have contributed to poor infant nutrition and obesity trends in Australia. Redressing healthcare system and industry practices to restore a supportive environment for breastfeeding is thus argued to be a necessary element of the public health response to the current obesity problem.

Keywords:
MeSH Terms: Adolescent Advertising/statistics & numerical data Australia/epidemiology Breast Feeding/statistics & numerical data Child Humans Infant Infant Food*/economics Infant Formula Infant Nutrition Physiology Marketing* Obesity/epidemiology Obesity/etiology* Public Policy

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.